Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation

Transplantation

Volumn 61, Issue 3, 1996, Pages 427-430

  Kesten, Steven ^a,b   Rajagopalan, N ^a   Maurer, Janet ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIBODY;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CYTOLYSIS; FORCED EXPIRATORY VOLUME; GRAFT SURVIVAL; HEART LUNG TRANSPLANTATION; HUMAN; LUNG TRANSPLANTATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; ANTILYMPHOCYTE SERUM; BRONCHIOLITIS OBLITERANS; FORCED EXPIRATORY VOLUME; GANCICLOVIR; HUMANS; LUNG TRANSPLANTATION; MIDDLE AGED; SYNDROME;

EID: 0030021354     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602150-00019     Document Type: Article

References (13)

1. Maurer JR, Morrison D, Winton TL, Patterson GA. Late pulmonary complications of isolated lung transplantation. Transplant Proc 1991; 23: 1224.
2. Scott JP, Higenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51: 813.
3. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713.
4. Scott JP, Higenbottom TW, Clelland C, Hutter JA, Stewart S, Wallwork J. The natural history of obliterative bronchiolitis and cellular vascular disease of patients following heart-lung transplantation. Transplant Proc 1989; 21: 2592.
5. Kramer MR, Stoehr C, Whang JL, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial biopsy. J Heart Lung Transplant 1993; 12: 675.
6. Allen MD, Burke CM, McGregor GA. Steroid responsive bronchiolitis after human heart-lung transplantation. Thorac Cardiovasc Surg 1986; 92: 449.
7. Glanville AR, Baldwin JC, Burke CM, Theodore J, Robin ED. Obliterative bronchiolitis after heart-lung transplantation, apparent arrest by augmented immunosuppression. Ann Intern Med 1987; 107: 300.
8. Yousem SA, Dauber JA, Keenan R, Paradis IL, Zeevi A, Griffith BP. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1990; 52: 306.
9. Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 1994; 13: 963.
10. Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection study group. J Heart Transplant 1990; 9: 593.
11. Zeevi A, Rabinowich H, Yousem SA, et al. Presence of donor specific alloreactivity in histologically normal allografts is predictive of subsequent brorichiolitis obliterans. Transplant Proc 1991; 23: 1128.
12. Shaddy RE, Bullock EA, Tani LY, et al. Methotrexate therapy in pediatric heart transplantation as treatment of recurrent mild to moderate acute cellular rejection. J Heart Lung Transplant 1994; 13: 1009.
13. Reinsmoen NL, Bolman RM, Savik K, Butters K, Hertz M. Are multiple immunopathogenetic events occurring during the development of obliterative bronciholitis and acute rejection? Transplantation 1993; 55: 1040.